As of 2025-07-19, the Relative Valuation of TCR2 Therapeutics Inc (TCRR) is (88.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of TCR2 Therapeutics Inc based on Relative Valuation is -6099.7%.
The range of the Relative Valuation is (56.08) - (110.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 26.7x | 19.8x |
| Forward P/E multiples | 13.5x - 32.3x | 22.9x |
| Fair Price | (56.08) - (110.92) | (88.79) |
| Upside | -3889.3% - -7594.3% | -6099.7% |
| Date | P/E |